Listing 1 - 10 of 13 | << page >> |
Sort by
|
Choose an application
Bacteriophages are viruses that utilise bacterial cells as factories for their own propagation and as safe havens for their genomic material. They are capable of equipping bacteria with properties that bestow environmental advantages. They are also capable of specifically and efficiently killing bacteria.Bacteriophages are resilient in a wide diversity of environments, presumed to be as ancient as life itself, and are estimated to be the most numerous biological entities on the planet. Their overarching capacity to survive via molecular adaptation is supported by an arsenal of encoded enzymatic tools, which also enabled biotechnology. This volume includes contributions that describe bacteriophages as nanomachines, genetic engineers, and also as medicines and technologies of the future, including relevant production and process issues.
Choose an application
As pathogenic bacteria continue to develop multi-drug resistance, antibacterial treatment strategies such as bacteriophages are needed. This book serves as a brief yet exhaustive guide to the biology of bacteriophages and their role in health and disease. It is a useful resource for microbiologists, bacteriophage researchers, clinicians providing bacteriophage therapy, and dental and medical students.
Choose an application
This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact
Antibacterial --- Bacteriophages --- Probiotics --- antibiotic resistance --- Antibiofilm --- antibiotic derivatives
Choose an application
Since the late 1800s, the discovery of new viruses was a gradual process. Viruses were described one by one using a suite of techniques such as (electron) microscopy and viral culture. Investigators were usually interested in a disease state within an organism, and expeditions in viral ecology were rare. The advent of metagenomics using high-throughput sequencing has revolutionized not only the rate of virus discovery, but also the nature of the discoveries. For example, the viral ecology and etiology of many human diseases are being characterized, non-pathogenic viral commensals are ubiquitous, and the description of environmental viromes is making progress. This Frontiers in Virology Research Topic showcases how metagenomic and bioinformatic approaches have been combined to discover, classify and characterize novel viruses.
virome --- biological dark matter --- metagenome --- metagenomics --- bacteriophages --- bioinformatics --- virus discovery --- phages
Choose an application
Viruses infect numerous microorganisms including, predominantly, Bacteria (bacteriophages or phages) but also Archaea, Protists, and Fungi. They are the most abundant and ubiquitous biological entities on Earth and are important drivers of ecosystem functioning. Little is known, however, about the vast majority of these viruses of microorganisms, or VoMs. Modern techniques such as metagenomics have enabled the discovery and description of more presumptive VoMs than ever before, but also have exposed gaps in our understanding of VoM ecology. Exploring the ecology of these viruses – which is how they interact with host organisms, the abiotic environment, larger organisms, and even other viruses across a variety of environments and conditions – is the next frontier. Integration of a growing molecular understanding of VoMs with ecological studies will expand our knowledge of ecosystem dynamics. Ecology can be studied at multiple levels including individual organisms, populations, communities, whole ecosystems, and the entire biosphere. Ecology additionally can consider normal, equilibrium conditions or instead perturbations. Perturbations are of particular interest because measuring the effect of disturbances on VoM-associated communities provides important windows into how VoMs contribute to ecosystem dynamics. These disturbances in turn can be studied through in vitro, in vivo, and in situ experimentation, measuring responses by VoM-associated communities to changes in nutrient availability, stress, physical disruption, seasonality, etc., and could apply to studies at all ecological levels. These are considered here across diverse systems and environments.
Viruses --- Microorganisms. --- Ecology. --- metaviromes --- environmental disturbance --- phage ecology --- bacteriophages --- phage therapy --- aquatic microbiology --- evolution --- microarrays
Choose an application
In the context of disease pathogenesis, it has been observed that after inadequate administration of antibiotics, animals become more susceptible to intestinal colonization and organ invasion by enteropathogens, these could be related to changes caused in the gastrointestinal microbial community. Therefore, we must reconsider the negative consequences that disruption of the microbiome has in the biology of metazoans (dysbacteriosis). Alternations of the intestinal microbiota composition in animals can be caused by multiple factors, including the misuse of antibiotics, having as a result a negative impact on the development and function of the immune, endocrine, nervous, and digestive systems. For this reason, social concerns regarding the development of antibiotic-resistant microorganisms have resulted in an urgent necessity to find feasible alternatives to maintain animal health and performance without the use of antibiotic growth promoters (AGP), in order to sustain livestock production as an economically viable source of food for human consumption. Hence, research about AGP alternatives such as probiotics, prebiotics, phytochemicals, organic acids, enzymes, and vaccines has become a priority for many scientists around the world.
Bacteriophages. --- Food contamination. --- Gastrointestinal system --- Microbiology. --- Feed additives --- Antibiotics --- Livestock --- Antimicrobial resistance --- Microbiome
Choose an application
In biofilms, microorganisms are able to communicate together and assemble by themselves, creating a consortium with different properties from the original free-floating microorganisms. In fact, biofilm cells bind strongly to a living or non-living surface, enclosed in a self-produced extracellular matrix that is composed of extracellular polymeric substances. One benefit of this lifestyle is the increased resistance or tolerance to antimicrobial agents (e.g., antibiotics). Hence, research on the development of alternative strategies to prevent and control biofilms is highly relevant for society in terms of human health, industry and the environment. Different approaches to prevent or control biofilms using antibiotic alternative strategies were submitted to this Special Issue.
antibacterial drug --- vitamin B12 --- antisense oligonucleotides --- nucleic acid mimics --- LNA --- 2′OMe --- biocidal particles --- functionalization --- benzalkonium chloride --- Escherichia coli --- antimicrobial activity --- antimicrobial resistance --- natural alkylglycerols --- ether lipids --- 1-O-alkyl-sn-glycerols --- antibiofilm activity --- quorum sensing inhibition --- stainless steel --- polypropylene --- organic matter --- microbial resistance --- peracetic acid --- biofilms --- prosthesis-related infections --- heat shock --- ciprofloxacin --- antibacterial agents --- E. coli biofilms --- food contact surfaces --- biocontrol --- bacteriophages --- aluminum nitride --- composite --- antibacterial --- mechanical --- thermal --- cellulose acetate --- CAPE --- Candida --- antifungal --- biofilm --- apoptosis --- urinary tract devices --- probiotics --- Lactobacillus plantarum --- Lactobacillus rhamnosus --- displacement --- oral biofilm --- dental implants --- titanium implants --- antimicrobial --- surface coating --- anti-fouling --- n/a --- 2'OMe
Choose an application
There is talk of an upcoming antibiotic armageddon, with untreatable post-operative infections, and similarly untreatable complications after chemotherapy. Indeed, the now famous “O’Neill Report” (https://amr-review.org/) suggests that, by 2050, more people might die from antibiotic-resistant bacterial infections than from cancer. While we are still learning all the subtle drivers of antibiotic resistance, it seems increasingly clear that we need to take a “one health” approach, curtailing the use of antibiotics in both human and veterinary medicine. However, there are no new classes of antibiotics on our horizon. Maybe something that has been around “forever” can come to our rescue—bacteriophages! Nevertheless, it is also necessary to do things differently, and use these new antimicrobials appropriately. Therefore, an in-depth study of bacteriophage biology and case-by-case applications might be required. Whilst by no means comprehensive, this book does cover some of the many topics related to bacteriophages as antimicrobials, including their use in human therapy and aquaculture. It also explores the potential use of phage endolysins as substitutes of antibiotics in two sectors where there is an urgent need—human therapy and the agro-food industry. Last but not least, there is an excellent perspective article on phage therapy implementation.
bacteriophages --- dairy industry --- pathogens --- lactic acid bacteria --- fermentation failure --- biofilms --- antimicrobial resistance --- antimicrobials --- lysins --- horizontal gene transfer, transduction --- biofilm --- phage therapy --- resistance --- bacteriophage --- models --- agent based --- mass action --- bacterial phage resistance --- regression modeling --- MRSA --- Clostridium difficile --- Clostridium difficile infection --- microbiome --- in vitro fermentation model --- marine vibrios --- biological control --- aquaculture --- interactions --- vibriosis --- Aeromonas hydrophila --- Motile Aeromonas Septicemia --- MAS --- multiple-antibiotic-resistance --- striped catfish (Pangasianodon hypophthalmus) --- endolysin --- antibiotics --- one health --- protein engineering --- Aeromonas salmonicida --- furunculosis --- phage-resistant mutants --- proteins --- infrared spectroscopy --- lysin --- lytic enzyme --- peptidoglycan hydrolase --- antimicrobial --- antibacterial --- antibiotic resistance --- bacteriophage therapy --- Nagoya Protocol --- CRISPR CAS --- phage isolation --- phage resistance --- Staphylococcus --- Kayvirus --- Vibrio anguillarum --- fish larvae --- challenge trials --- phage display --- enzybiotics --- Bacteriophages --- diabetic foot ulcer --- osteomyelitis --- Staphylococcus aureus --- Antibiotic-resistant bacteria --- lysogenic conversion --- prophage induction --- read recruitment --- shiga toxin --- American Foulbrood --- phage --- Paenibacillus larvae --- Brevibacillus laterosporus --- treatment --- safety --- bystander phage therapy --- Mycobacterium smegmatis --- mycobacteriophages --- directed evolution --- PlyC CHAP --- protein net charge --- CBD-independent --- FoldX --- STEC-specific bacteriophage --- whole genome sequencing --- STEC O145 strains --- antimicrobial agent --- Pseudomonas aeruginosa --- dual-species --- antibiotic --- synergy --- simultaneous --- sequential --- microbiome therapy --- evolution
Choose an application
[Increasing evidence suggests that microbiota and especially the gut microbiota (the microbes inhabiting the gut including bacteria, archaea, viruses, and fungi) plays a key role in human physiology and pathology. Recent findings indicate how dysbiosis—an imbalance in the composition and organization of microbial populations—could severely impact the development of different medical conditions (from metabolic to mood disorders), providing new insights into the comprehension of diverse diseases, such as IBD, obesity, asthma, autism, stroke, diabetes, and cancer. Given that microbial cells in the gut outnumber host cells, microbiota influences human physiology both functionally and structurally. Microbial metabolites bridge various—even distant—areas of the organism by way of the immune and hormone system. For instance, it is now clear that the mutual interaction between the gastrointestinal tract and the brain (gut–brain axis), often involves gut microbiota, indicating that the crosstalk between the organism and its microbial residents represents a fundamental aspect of both the establishment and maintenance of healthy conditions. Moreover, it is crucial to recognize that beyond the intestinal tract, microbiota populates other host organs and tissues (e.g., skin and oral mucosa). We have edited this eBook with the aim of publishing manuscripts focusing on the impact of microbiota in the development of different diseases and their associated treatments.]
gastrointestinal diseases --- sterile inflammation --- n/a --- Staphylococcus spp. --- etiopathogenesis --- colitis --- Escherichia coli --- bacteriophages --- atopic dermatitis --- intravenous immunoglobulin G --- adaptive immunity --- 16S rRNA gene --- vaginal microbiota --- modularity --- innate immunity --- gut-liver axis --- disease activity --- immune system --- cytokines --- commensals --- Staphylococcus aureus --- dysbiosis --- fecal transplantation --- TLR mimicry --- etanercept --- dextran sulfate sodium --- CAR T-cell --- 3-dihydroxy-4-methoxyBenzaldehyde --- chemo free treatment --- Staphylococcus epidermis --- rheumatoid arthritis --- microbiome --- co-occurrence network --- immune epigenetics --- 2 --- autoimmunity --- superoxide dismutase --- precision medicine --- metabolism --- adoptive cell transfer (ACT) --- gut barrier --- antibiotics --- checkpoint inhibitors --- probiotics --- microbiota --- Candida albicans --- Enterococcus faecalis --- chronic liver diseases --- TCR --- anaerobic bacteria --- HSV2 --- bacteriocins --- methotrexate --- microbial interactions --- T cells --- virus --- mice --- lymphoid malignancies --- HPV --- macrophages --- anti-TNF-? --- inflammation --- chondroitin sulfate disaccharide --- immunotherapy --- genomics --- immuno-oncology --- diet --- aerobic bacteria --- immunological niche --- melanin --- health --- chemokines --- gut microbiota --- cutaneous immunity --- HIV --- TIL --- cancer --- global network
Choose an application
Phages have shown a high biotechnological potential with numerous applications. The advent of high-resolution microscopy techniques aligned with omic and molecular tools have revealed innovative phage features and enabled new processes that can be further exploited for biotechnological applications in a wide variety of fields. The high-quality original articles and reviews presented in this Special Issue demonstrate the incredible potential of phages and their derived proteins in a wide range of biotechnological applications for human benefit. Considering the emergence of amazing new available bioengineering tools and the high abundance of phages and the multitude of phage proteins yet to be discovered and studied, we believe that the upcoming years will present us with many more fascinating and new previously unimagined phage-based biotechnological applications.
toxicity --- encapsulation --- n/a --- cancerous tumors --- bacteriophage-derived lytic enzyme --- native gel electrophoresis --- bacteriophages --- Cpl-1 --- O-antigen --- ESKAPE --- Clostridium perfringens --- X-ray crystallography --- macromolecular interactions --- safety --- biofilm --- major coat protein --- Streptococcus agalactiae --- Staphylococcus aureus --- tail sheath protein --- magnetic separation --- serotyping --- pathogenic viruses --- liposomes --- tuberculosis --- Listeria monocytogenes --- nanotubular structures --- alpha-sheet --- biosensors --- sarcoidosis --- tailspike proteins --- M13 bacteriophage --- Streptococcus pneumoniae --- gene expression regulation --- bacteriophage recombination --- self-assembly --- phage therapy --- R-type pyocin --- contractile injection systems --- bacteriophage vB_EcoM_FV3 --- microtiter plate assay --- Enterococcus faecalis --- culture enrichment --- drug delivery vehicles --- neurodegenerative disease --- landscape phage --- niosomes --- bacteriophage --- Myoviridae --- bacteriophage evolution --- porous structure --- phage-host interaction --- phage display --- immune response --- antibiotic resistance --- Pseudomonas aeruginosa --- phage --- bacteriocin --- Appelmans --- fluorescence sensor --- molecular probe --- nanomedicine --- Shigella flexneri --- reporter phage --- filters --- in vitro activity --- capsid dynamics --- immunoscreening --- diagnostics --- microarray --- receptor-binding protein --- endolysin --- enzybiotics --- transfersomes --- T7phage library --- Pal
Listing 1 - 10 of 13 | << page >> |
Sort by
|